BA
EXAS

Broadview Advisors’s Exact Sciences EXAS Stock Holding History

Broadview Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-99,629
Closed -$3.52M – 104
2017
Q2 		$3.52M Sell
99,629
-440,420
-82% -$13.6M 0.52% 65
2017
Q1 		$12.8M Sell
540,049
-17,950
-3% -$356K 1.76% 16
2016
Q4 		$7.46M Sell
557,999
-18,482
-3% -$298K 1% 41
2016
Q3 		$10.7M Buy
576,481
+5,600
+1% +$98.7K 1.52% 25
2016
Q2 		$6.99M Buy
570,881
+169,050
+42% +$1.27M 1.05% 45
2016
Q1 		$2.71M Buy
401,831
+850
+0.2% +$5.44K 0.39% 68
2015
Q4 		$3.7M Sell
400,981
-137,319
-26% -$1.28M 0.52% 62
2015
Q3 		$9.68M Buy
538,300
+2,675
+0.5% +$61.4K 1.34% 36
2015
Q2 		$15.9M Sell
535,625
-14,625
-3% -$367K 1.68% 17
2015
Q1 		$12.1M Sell
550,250
-259,700
-32% -$6.59M 1.2% 34
2014
Q4 		$22.2M Sell
809,950
-123,900
-13% -$3.02M 2.26% 10
2014
Q3 		$18.1M Buy
933,850
+219,550
+31% +$4.03M 1.98% 14
2014
Q2 		$12.2M Buy
+714,300
New +$9.84M 1.18% 39

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Broadview Advisors's EXAS Position: Q3 2017 in Review

Broadview Advisors sold out of Exact Sciences (EXAS) in Q3 2017, closing a stake of 99,629 shares — an estimated $3.52M sold.

Broadview Advisors first reported a position in EXAS in Q2 2014 and held it in 13 quarters. The position peaked at $22.2M in Q4 2014. 282 funds tracked by Wall St. Rank hold EXAS as of Q3 2017.

  • Broadview Advisors reported no remaining Exact Sciences position as of Q3 2017 after selling out during the quarter.
  • Broadview Advisors sold 99,629 Exact Sciences shares in Q3 2017, an estimated $3.52M.
  • Broadview Advisors first reported a position in Exact Sciences in Q2 2014 and held it in 13 quarters.
  • Broadview Advisors's Exact Sciences position peaked at $22.2M in Q4 2014.
  • 282 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2017.

Based on Broadview Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.